142 related articles for article (PubMed ID: 28196708)
1. Design, synthesis and biological evaluation of 2,4-disubstituted oxazole derivatives as potential PDE4 inhibitors.
Li YS; Hu DK; Zhao DS; Liu XY; Jin HW; Song GP; Cui ZN; Zhang LH
Bioorg Med Chem; 2017 Mar; 25(6):1852-1859. PubMed ID: 28196708
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors.
Li YS; Tian H; Zhao DS; Hu DK; Liu XY; Jin HW; Song GP; Cui ZN
Bioorg Med Chem Lett; 2016 Aug; 26(15):3632-5. PubMed ID: 27289320
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and bioactivity of 3,5-dimethylpyrazole derivatives as potential PDE4 inhibitors.
Hu DK; Zhao DS; He M; Jin HW; Tang YM; Zhang LH; Song GP; Cui ZN
Bioorg Med Chem Lett; 2018 Oct; 28(19):3276-3280. PubMed ID: 30131240
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and bioactivity of phenyl substituted furan and oxazole carboxylic acid derivatives as potential PDE4 inhibitors.
Lin Y; Ahmed W; He M; Xiang X; Tang R; Cui ZN
Eur J Med Chem; 2020 Dec; 207():112795. PubMed ID: 33002845
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydroquinoline and tetrahydroisoquinoline derivatives as potential selective PDE4B inhibitors.
Li YS; Liu XY; Zhao DS; Liao YX; Zhang LH; Zhang FZ; Song GP; Cui ZN
Bioorg Med Chem Lett; 2018 Oct; 28(19):3271-3275. PubMed ID: 30131242
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Song G; Zhao D; Hu D; Li Y; Jin H; Cui Z
Bioorg Med Chem Lett; 2015 Oct; 25(20):4610-4. PubMed ID: 26320621
[TBL] [Abstract][Full Text] [Related]
7. Rational design of conformationally constrained oxazolidinone-fused 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Song G; Zhu X; Li J; Hu D; Zhao D; Liao Y; Lin J; Zhang LH; Cui ZN
Bioorg Med Chem; 2017 Oct; 25(20):5709-5717. PubMed ID: 28888661
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design and structure-activity relationships of 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Liao Y; Guo Y; Li S; Wang L; Tang Y; Li T; Chen W; Zhong G; Song G
Bioorg Med Chem Lett; 2018 Apr; 28(7):1188-1193. PubMed ID: 29545101
[TBL] [Abstract][Full Text] [Related]
9. Conformationally restricted novel pyrazole derivatives: synthesis of 1,8-disubstituted 5,5-dimethyl-4,5-dihydro-1H-benzo[g]indazoles as a new class of PDE4 inhibitors.
Reddy TS; Kumar KS; Meda CL; Kandale A; Rambabu D; Krishna GR; Hariprasad C; Rao VV; Venkataiah S; Reddy CM; Naidu A; Dubey PK; Parsa KV; Pal M
Bioorg Med Chem Lett; 2012 May; 22(9):3248-55. PubMed ID: 22464134
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis.
Purushothaman B; Arumugam P; Kulsi G; Song JM
Eur J Med Chem; 2018 Feb; 145():673-690. PubMed ID: 29353721
[TBL] [Abstract][Full Text] [Related]
11. Discovery of oral and inhaled PDE4 inhibitors.
Ting PC; Lee JF; Kuang R; Cao J; Gu D; Huang Y; Liu Z; Aslanian RG; Feng KI; Prelusky D; Lamca J; House A; Phillips JE; Wang P; Wu P; Lundell D; Chapman RW; Celly CS
Bioorg Med Chem Lett; 2013 Oct; 23(20):5528-32. PubMed ID: 24018187
[TBL] [Abstract][Full Text] [Related]
12. PdCl
Thirupataiah B; Mounika G; Reddy GS; Kumar JS; Hossain KA; Medishetti R; Samarpita S; Rasool M; Mudgal J; Mathew JE; Shenoy GG; Rao CM; Chatti K; Parsa KVL; Pal M
Eur J Med Chem; 2021 Oct; 221():113514. PubMed ID: 33992926
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 5-carbamoyl-2-phenylpyrimidine derivatives as novel and potent PDE4 inhibitors.
Goto T; Shiina A; Yoshino T; Mizukami K; Hirahara K; Suzuki O; Sogawa Y; Takahashi T; Mikkaichi T; Nakao N; Takahashi M; Hasegawa M; Sasaki S
Bioorg Med Chem; 2013 Nov; 21(22):7025-37. PubMed ID: 24094436
[TBL] [Abstract][Full Text] [Related]
14. Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors.
Gorja DR; Mukherjee S; Meda CL; Deora GS; Kumar KL; Jain A; Chaudhari GH; Chennubhotla KS; Banote RK; Kulkarni P; Parsa KV; Mukkanti K; Pal M
Org Biomol Chem; 2013 Apr; 11(13):2075-9. PubMed ID: 23436140
[TBL] [Abstract][Full Text] [Related]
15. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis.
Chu Z; Xu Q; Zhu Q; Ma X; Mo J; Lin G; Zhao Y; Gu Y; Bian L; Shao L; Guo J; Ye W; Li J; He G; Xu Y
Eur J Med Chem; 2021 Mar; 213():113171. PubMed ID: 33482600
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel quinazoline-based anti-inflammatory agents acting as PDE4B inhibitors.
Serya RA; Abbas AH; Ismail NS; Esmat A; Abou El Ella DA
Chem Pharm Bull (Tokyo); 2015; 63(2):102-16. PubMed ID: 25748781
[TBL] [Abstract][Full Text] [Related]
18. Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors.
Kawasaki M; Fusano A; Nigo T; Nakamura S; Ito MN; Teranishi Y; Matsumoto S; Toda H; Nomura N; Sumiyoshi T
Bioorg Med Chem Lett; 2014 Jun; 24(12):2689-92. PubMed ID: 24794103
[TBL] [Abstract][Full Text] [Related]
19. Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
Chłoń-Rzepa G; Ślusarczyk M; Jankowska A; Gawalska A; Bucki A; Kołaczkowski M; Świerczek A; Pociecha K; Wyska E; Zygmunt M; Kazek G; Sałat K; Pawłowski M
Eur J Med Chem; 2018 Oct; 158():517-533. PubMed ID: 30245393
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Docking and Anti-Inflammatory Activity of Triazole Amine Derivatives as Potential Phosphodiesterase-4 Inhibitors.
Grewal AS; Lather V; Pandita D; Dalal R
Antiinflamm Antiallergy Agents Med Chem; 2017; 16(1):58-67. PubMed ID: 28618988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
